A recent report by Ceol and colleagues demonstrated that melanoma associated mGluR3 variant signaling downregulates cAMP signaling that affects melanosome trafficking that may contribute to melanomagenesis from cross talks between cAMP and MAPK signaling cascades and lead to drug resistance, however, further validation is needed [124]. Here, GRM3 is linked to melanoma.